Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 14 to 18, 2020. This …
Botox for TMJ Disorder Does Not Affect Jaw Bone Density
Low-dose botulinum toxin injections for jaw, facial pain not linked to short-term bone changes
BP Control Down in the United States From 2013-2014 to 2017-2018
BP control, awareness, treatment down in adults aged 40 to 59 years from 2009-2012 to 2015-2018
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
Canada Reports No New COVID-19 Deaths for First Time in Six Months
As of Saturday, there had been 137,676 COVID-19 cases and 9,214 deaths from the illness in Canada
AstraZeneca COVID-19 Vaccine Trial Restarts
Trial was halted after a suspected adverse reaction in a patient
Effectiveness of Inhaled COVID-19 Vaccines to Be Studied
Trial will test responses of 30 adults when they inhale vaccine droplets in their mouths
Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients
Adding anti-inflammatory drug to remdesivir seems to shorten time to hospital discharge
Coronary Artery Calcium Score IDs Coronary Heart Disease Risk
Predictive value for coronary heart disease risk similar across sex and racial groups
One or More Opioids Involved in ~80 Percent of OD Deaths
At least one potential opportunity for prevention intervention for 62.7 percent of overdose deaths